Article info

Download PDFPDF
Original research article
Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis

Authors

  1. Correspondence to Dr Sheyu Li, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China and Division of Population Health & Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, DD1 9SY, Scotland, UK; lisheyu{at}gmail.com
View Full Text

Citation

Du H, Li X, Su N, et al
Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis

Publication history

  • Received January 16, 2019
  • Revised January 28, 2019
  • Accepted January 30, 2019
  • First published March 6, 2019.
Online issue publication 
July 15, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.